Exelixis (EXEL) Tops Q3 EPS by 9c, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts EXEL Hot Sheet
Price: $72.75 +0.61%
Financial Fact:
Research and development: 22.98M
Today's EPS Names:
COHR, ATS, SICP, More
Financial Fact:
Research and development: 22.98M
Today's EPS Names:
COHR, ATS, SICP, More
Join SI Premium – FREE
Exelixis (NASDAQ: EXEL) reported Q3 EPS of $0.78, $0.09 better than the analyst estimate of $0.69. Revenue for the quarter came in at $597.8 million versus the consensus estimate of $590.47 million.
GUIDANCE:
Exelixis sees FY2025 revenue of $2.3-2.35 billion, versus the consensus of $2.319 billion.
For earnings history and earnings-related data on Exelixis (EXEL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vertex (VERX) Tops Q3 EPS by 4c; Offers Guidance
- Enact Holdings (ACT) Reports In-Line Q3 EPS
- ACRES Commercial Realty (ACR) Misses Q3 EPS by 526c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
